![](/images/graphics-bg.png)
Comparison study of the effect of erlotinib as a tyrosine kinase inhibitor on electrolyte levels in type2 diabetic and diabetic nephropathy
Joint Authors
al-Khudayri, Zaynab Mahdi Abd
Ali, Bushra H.
Source
Ibn al-Haitham Journal for Pure and Applied Science
Issue
Vol. 31, Issue 3 (31 Dec. 2018), pp.63-69, 7 p.
Publisher
University of Baghdad College of Education for Pure Science / Ibn al-Haitham
Publication Date
2018-12-31
Country of Publication
Iraq
No. of Pages
7
Main Subjects
Abstract EN
Diabetes mellitus can be defined as a metabolic disorder disease.
Complication of diabetes are due to diabetic nephropathy.
This study was done in vitro to study the effect of different concentrations of erlotinib inhibitor (tyrosine kinase inhibitor) on electrolyte levels (Mg⁺², Ca⁺², Na⁺) in sera of Iraqi patients with newly diagnosis type2 diabetes and diabetic nephropathy in addition to find the best percentage inhibition for utilizing different concentrations from erlotinib (6.97x10⁻⁷, 9.30x10⁻⁷ ,1.16x10⁻⁶,1.39x10⁻⁶ ,1.62x10⁻⁵) molar on electrolyte levels.
This study was conducted in The National Diabetes Center, Al- Mustansiriya University - Baghdad and included 150 patients divided into50 patients type 2 diabetic as group (G2), 50patients diabetic nephropathy as group(G3) and also 50 healthy as control group(G1).
The period time for aggregation the blood sampling was from July to October 2017.
All patients were within (18 to 60) year's age.
Erlotinib (Tyrosine kinase inhibitor) affected on serum Mg ⁺²levels in human as a mild effect and a slight effect on serum Na⁺ and Ca⁺².The best inhibition of erlotinib in concentration (1.62x10⁻5) M for both serum Na⁺ and Ca⁺² in newly diagnosis diabetes type 2 and diabetic nephropathy.
Serum Mg ⁺²levels showed best inhibition in concentration (9.30x10⁻7) M.
American Psychological Association (APA)
al-Khudayri, Zaynab Mahdi Abd& Ali, Bushra H.. 2018. Comparison study of the effect of erlotinib as a tyrosine kinase inhibitor on electrolyte levels in type2 diabetic and diabetic nephropathy. Ibn al-Haitham Journal for Pure and Applied Science،Vol. 31, no. 3, pp.63-69.
https://search.emarefa.net/detail/BIM-900648
Modern Language Association (MLA)
al-Khudayri, Zaynab Mahdi Abd& Ali, Bushra H.. Comparison study of the effect of erlotinib as a tyrosine kinase inhibitor on electrolyte levels in type2 diabetic and diabetic nephropathy. Ibn al-Haitham Journal for Pure and Applied Science Vol. 31, no. 3 (2018), pp.63-69.
https://search.emarefa.net/detail/BIM-900648
American Medical Association (AMA)
al-Khudayri, Zaynab Mahdi Abd& Ali, Bushra H.. Comparison study of the effect of erlotinib as a tyrosine kinase inhibitor on electrolyte levels in type2 diabetic and diabetic nephropathy. Ibn al-Haitham Journal for Pure and Applied Science. 2018. Vol. 31, no. 3, pp.63-69.
https://search.emarefa.net/detail/BIM-900648
Data Type
Journal Articles
Language
English
Notes
Text in English ; abstracts in Arabic.
Record ID
BIM-900648